AU2003203883A1 - Pharmaceutical uses of optically pure(+) - Bupropion - Google Patents

Pharmaceutical uses of optically pure(+) - Bupropion

Info

Publication number
AU2003203883A1
AU2003203883A1 AU2003203883A AU2003203883A AU2003203883A1 AU 2003203883 A1 AU2003203883 A1 AU 2003203883A1 AU 2003203883 A AU2003203883 A AU 2003203883A AU 2003203883 A AU2003203883 A AU 2003203883A AU 2003203883 A1 AU2003203883 A1 AU 2003203883A1
Authority
AU
Australia
Prior art keywords
bupropion
optically pure
pharmaceutical uses
pharmaceutical
optically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003203883A
Inventor
James W Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of AU2003203883A1 publication Critical patent/AU2003203883A1/en
Abandoned legal-status Critical Current

Links

AU2003203883A 1998-01-29 2003-04-24 Pharmaceutical uses of optically pure(+) - Bupropion Abandoned AU2003203883A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60072955 1998-01-29

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU24834/99A Division AU2483499A (en) 1998-01-29 1999-01-28 Pharmaceutical uses of optically pure (+)-bupropion

Publications (1)

Publication Number Publication Date
AU2003203883A1 true AU2003203883A1 (en) 2003-06-12

Family

ID=

Similar Documents

Publication Publication Date Title
EP1001813B8 (en) Pharmaceutical formulations containing voriconazole
AU1225000A (en) Combined pharmaceutical estrogen-androgen-progestin
AU1936401A (en) Photodefinition of optical devices
AU5476396A (en) Pharmaceutical compositions containing irbesartan
AUPN411195A0 (en) Medicinal composition
AU6740298A (en) Pharmaceutical composition
AU5799098A (en) Preparation of gabapentin
AU8107998A (en) Pharmaceutical compositions
AU4779399A (en) Pharmaceutical levothyroxine preparation
AU8591898A (en) Pharmaceutical compounds
AU5155096A (en) Pharmaceutical composition
AU7904998A (en) Pharmaceutical composition containing peptichemio
AU5570899A (en) Purified human papillomavirus
AU9343098A (en) Pharmaceutical composition
AU8698898A (en) High purity alkoxytrimethylsilane fluids
AU1044799A (en) Pharmaceutical composition containing zafirlukast
AU3191597A (en) Novel medicinal compositions of hydropyridines
AU3490499A (en) Vision architecture to describe features of persons
AU2241699A (en) Expression of proteolytically-sensitive peptides
AUPP332898A0 (en) Pharmaceutical composition
AU3615697A (en) External fixator
AU1800100A (en) Medicinal preparations
AU8102498A (en) Preparation of diaryl-benzopyrans
AU7711800A (en) Novel uses of 2-bromopalmitate
AU2003203883A1 (en) Pharmaceutical uses of optically pure(+) - Bupropion